Showing results (91-100 of 31,559) with videos related to

Sort By:
Pageof 3,156
Child Abuse & Neglect|October 1, 2013
Child homicide and neglect in France: 1991-2008F Makhlouf, C Rambaud
International Journal of Pharmaceutics|February 3, 2023
Hair regrowth boosting via minoxidil cubosomes: Formulation development, in vivo hair regrowth evaluation, histopathological examination and confocal laser microscopy imagingAmal Makhlouf, Tayseer Elnawawy
Structure (London, England : 1993)|August 8, 2025
Unlocking the MIT gate: STAM activates AMSH autoinhibitionLinda Makhlouf, Elton Zeqiraj
The Biochemical Journal|April 3, 2025
Sequence rules for a long SPOP-binding degron required for protein ubiquitylationLinda Makhlouf, Mukul Mishra, Hannah Makhlouf, et al.
Anti-Cancer Drug Design|September 1, 1995
Prodrugs of anthracycline antibiotics suited for tumor-specific activationM Azoulay, J C Florent, C Monneret, et al.
Chemical & Pharmaceutical Bulletin|March 3, 2004
Synthesis and cytotoxic and antitumor activity of 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diacid hemiesters and carbamatesHuong Doan Thi Mai, Thomas Gaslonde, Sylvie Michel, et al.
Oncogene|December 29, 2000
Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosisV Deguin-Chambon, M Vacher, M Jullien, et al.
Magma (New York, N.Y.)|March 1, 1997
Pulsed gradient analysis using a dedicated magnetometerP Desgoutte, L Chaabane, B Favre, et al.
Molecular Pharmacology|November 28, 2001
Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosisS Léonce, V Pérez, S Lambel, et al.
Anti-Cancer Drug Design|October 1, 1994
Prodrugs of anthracyclines for chemotherapy via enzyme-monoclonal antibody conjugatesJ P Gesson, J C Jacquesy, M Mondon, et al.
Pageof 3,156